Neurological outcomes associated with low-level manganese exposure in an inception cohort of asymptomatic welding trainees.
Neurological outcomes associated with low-level manganese exposure in an inception cohort of asymptomatic welding trainees.
复制标题
与低水平锰暴露有关的神经结局,在无症状焊接学员中。
DOI:
10.5271/sjweh.3466
复制
发表时间:
2015-01
期刊:
影响因子:
--
通讯作者:
Seixas NS
中科院分区:
文献类型:
--
作者:
Baker MG;Criswell SR;Racette BA;Simpson CD;Sheppard L;Checkoway H;Seixas NS
Long-term, high-level exposure to manganese (Mn) is associated with impaired central nervous system (CNS) function. We quantitatively explored relations between low-level Mn exposure and selected neurological outcomes in a longitudinal inception cohort of asymptomatic welder trainees. Welders with no previous occupational Mn exposure were observed approximately every three months over the course of the five-quarter traineeship. Fifty-six welders were assessed for motor function using the Unified Parkinson Disease Rating Scale motor subsection part 3 (UPDRS3) and Grooved Pegboard tests. A subset of 17 also had MRI scans to assess T1-weighted indices. Personal exposure to Mn in welding fume was quantitatively assessed during the study period using a mixed model to obtain estimates of subject-specific exposure level by welding type. These estimates were summed to estimate cumulative exposure at the time of each neurological outcome test. When adjusting for possible learning effects, there were no associations between cumulative exposure and UPDRS3 score or Grooved Pegboard time. T1-weighted indices of the basal ganglia (caudate, anterior putamen, posterior putamen, and combined basal ganglia, but not the pallidal index) exhibited statistically significant increases in signal intensity in relation to increased cumulative Mn exposure. This study demonstrates that T1-weighted changes can be detected in the brain even at very low levels of exposure among humans before any clinically evident deficits. This suggests that with continued follow-up we could identify a T1 threshold of toxicity at which clinical symptoms begin to manifest.
登录
查看更多内容
影响因子:
2
作者:
Baker MG;Simpson CD;Stover B;Sheppard L;Checkoway H;Racette BA;Seixas NS
通讯作者:
Seixas NS
影响因子:
3.4
作者:
Laohaudomchok W;Lin X;Herrick RF;Fang SC;Cavallari JM;Shrairman R;Landau A;Christiani DC;Weisskopf MG
通讯作者:
Weisskopf MG
影响因子:
4.4
作者:
LARSEN N A;PAKKENBERG H;HEYDORN K
通讯作者:
HEYDORN K
影响因子:
3.4
作者:
Antonini, James M.;Santaimaria, Annette B.;Lucchini, Roberto
通讯作者:
Lucchini, Roberto
影响因子:
4.9
作者:
Criswell SR;Perlmutter JS;Huang JL;Golchin N;Flores HP;Hobson A;Aschner M;Erikson KM;Checkoway H;Racette BA
通讯作者:
Racette BA